<?xml version="1.0" encoding="UTF-8"?>
<ref id="B41">
 <label>41</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>da Cruz</surname>
    <given-names>RMD</given-names>
   </name>
   <name>
    <surname>Batista</surname>
    <given-names>TM</given-names>
   </name>
   <name>
    <surname>de Sousa</surname>
    <given-names>TKG</given-names>
   </name>
   <name>
    <surname>Mangueira</surname>
    <given-names>VM</given-names>
   </name>
   <name>
    <surname>Dos Santos</surname>
    <given-names>JAF</given-names>
   </name>
   <name>
    <surname>de Abrantes</surname>
    <given-names>RA</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Coumarin derivative 7-isopentenyloxycoumarin induces in vivo antitumor activity by inhibit angiogenesis via CCL2 chemokine decrease</article-title>. 
  <source>Naunyn-Schmiedeberg’s Arch Pharmacol</source> (
  <year>2020</year>) 
  <volume>2020</volume>:
  <page-range>1701–14</page-range>.  
  <pub-id pub-id-type="doi">10.1007/s00210-020-01884-4</pub-id>
 </mixed-citation>
</ref>
